Novo-Backed MapLight Seeks $251 Million in US IPO, Placement

MapLight Therapeutics Inc., a biotechnology firm developing treatments for neurological disorders, is seeking to raise $250.8 million in an initial public offering and private placement, proceeding despite the US government shutdown complicating the listing process....

Redirecting to full article...